New Cholesterol-Lowering shot shows promise in major trial
NCT ID NCT07253584
First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study tested a new injectable medicine (SAL003) added to standard statin therapy in 720 adults with high cholesterol. The goal was to see if it safely lowers 'bad' LDL cholesterol more than a placebo. Participants had high cholesterol despite taking statins, and the treatment aims to help control their condition long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIAS, HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Xi 'an Jiaotong University
Xi’an, Shanxi, China
Conditions
Explore the condition pages connected to this study.